Author Correction: Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis

By afschroeder • February 6, 2026

Li S, Noor ZS, Zeng W, Stackpole ML, Ni X, Zhou Y, Yuan Z, Wong WH, Agopian VG, Dubinett SM, Alber F, Li W, Garon EB, Zhou XJ. Author Correction: Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis. Nat Commun. 2026 Feb 5;17(1):1388. doi: 10.1038/s41467-026-69268-5. Erratum for: Nat Commun. 2021 Jul 7;12(1):4172. doi: 10.1038/s41467-021-24457-2. PMID: 41644545.

Tags: Hematology/Oncology, Publications, Pulmonary, Critical Care & Sleep Medicine

Lentivirus-Based Hematopoietic Stem/Progenitor Cell Therapy Provides Effective and Long-Term Treatment in Hypophosphatasia Mouse Model

Carrillo M, Tomer S, Wang L, Cook E, Wennerberg W, Tien N, Ng H, Alagarsamy J, Rezek V, Martin H, Narisawa S, Millan JL, Crine[...]

Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival

Marsh LA, Kim TH, Zhang M, Kubalanza K, Treece CL, Chase D, Memarzadeh S, Salani R, Karlan B, Rao J, Konecny GE. Pathologic response to[...]

Comparative effectiveness of CDK4/6 inhibitors in metastatic breast cancer: using the target trial emulation framework to investigate overall survival in routine care

Brufsky AM, Finn RS, Metzger O, Goncalves R, Huang-Bartlett C, Sreenivasan S, Nur U, Davies J, Grigorenko A, Long GH. Comparative effectiveness of CDK4/6 inhibitors[...]